Insmed Inc (NASDAQ:INSM) shares, rose in value on Wednesday, June 18, with the stock price down by -0.82% to the previous day’s close as strong demand from buyers drove the stock to $99.46.
Actively observing the price movement in the last trading, the stock closed the session at $100.28, falling within a range of $98.46 and $101.408. The value of beta (5-year monthly) was 0.794. Referring to stock’s 52-week performance, its high was $102.00, and the low was $60.40. On the whole, INSM has fluctuated by 46.52% over the past month.
With the market capitalization of Insmed Inc currently standing at about $18.89 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-08.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that INSM’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of INSM currently trading nearly 24.76% and 35.73% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 76.72, while the 7-day volatility ratio is showing 2.03% which for the 30-day chart, stands at 6.12%. Furthermore, Insmed Inc (INSM)’s beta value is 0.79, and its average true range (ATR) is 3.92.
A comparison of Insmed Inc (INSM) with its peers suggests the former has fared considerably weaker in the market. INSM showed an intraday change of -0.82% in last session, and over the past year, it grew by 55.60%%.
Data on historical trading for Insmed Inc (NASDAQ:INSM) indicates that the trading volumes over the past 10 days have averaged 5.68 and over the past 3 months, they’ve averaged 2.90 million. According to company’s latest data on outstanding shares, there are 189.95 million shares outstanding.
Nearly 2.24% of Insmed Inc’s shares belong to company insiders and institutional investors own 104.85% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 17.46 million shares as on 2025-05-30, resulting in a short ratio of 7.75. According to the data, the short interest in Insmed Inc (INSM) stood at 1080.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 15.78 million. The stock has risen by 44.06% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the INSM stock heading into the next quarter.
